Our COO, Tanaka, and our business manager, Akane, Launched the IoMD working group at the Japan Digital Therapeutics Association.

Our COO Tanaka has been appointed as a health care expert.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer of Yokohama City University.

Our CSO, Hiroaki Kato, has been reappointed as a part-time lecturer of the Graduate School of Tohoku University.

Our CSO, Hiroaki Kato, has been reappointed as Clinical Associate Professor of Tokyo Medical and Dental University.

Our CSO, Hiroaki Kato, has been reappointed as Visiting Associate Professor of Chiba University Hospital.

Our CSO, Hiroaki Kato, has been re-elected as a councilor of the Japanese Society of Artificial Intelligence in Ophthalmology.

Our CSO, Hiroaki Kato, has become a committee member of Japanese Ophthalmological Society.

Aillis has published the transparency report for the year 2017.

Masaki Nomura has become our Chief Creative Officer.

Our website has been renewed.